Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled study of methadone vs buprenorphine in hepatitis C patients on opioid substitution
2005-000240-82Phase 4Completed
- Sponsor
- AESCA Pharma
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic hepatitis C (CHC) and opioid use disorder (OUD) comparing Methadone maintenance with Buprenorphine maintenance (2 arms). Primary endpoint: Primary efficacy of hepatitis C treatment. Started Mar 2005; status: completed.
02
Drugs
methadonebuprenorphine
03
Conditions
chronic hepatitis C (CHC)opioid use disorder (OUD)
Beyond the preview
Go deeper on 2005-000240-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000240-82.